DMAA seeks consensus on DM outcome measures

The new NIH study has shed light on the challenges faced by pregnant individuals living with HIV as hypertensive disorders in pregnancy pose a crucial health risk to expectant mothers.

Managed Healthcare Executive's Managing Editor Peter Wehrwein, and Editor Briana Contreras, had a discussion in July with Mostafa Kamal, president and CEO of Prime Therapeutics, an organization in which Kamal acquired this position that same month.

In a clinical trial, researchers found that the risk of retinopathy of prematurity (ROP) was reduced by 50% in infants who received fatty acid supplementation.

Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.

Iyuzeh is a preservative-free latanoprost product that can be stored at room temperature. It has a list price of $299 for a month’s supply.